Pediatrix Medical Group, Inc. (MD)
USD 14.01
(-1.48%)
USD 14.01
(-1.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 137.32 Million | 166.94 Million | 76.73 Million | 204.62 Million | 346.63 Million | 289.92 Million |
| Net Income | -60.4 Million | 62.56 Million | 108.01 Million | -9.58 Million | -1.15 Billion | 268.62 Million |
| Depreciation & Amortization | 36.17 Million | 35.63 Million | 32.14 Million | 28.44 Million | 78.86 Million | 111.28 Million |
| Deferred income taxes | 3.23 Million | -22.77 Million | -31.23 Million | 36.29 Million | -177 Million | -24.14 Million |
| Stock-based compensation | 12.32 Million | 16.12 Million | 18.96 Million | 39.04 Million | 35.35 Million | 38.7 Million |
| Change in working capital | -11.62 Million | 31.82 Million | -23.35 Million | 52.72 Million | 97.24 Million | -97.11 Million |
| Other non-cash items | 157.62 Million | 43.55 Million | -27.79 Million | 57.69 Million | 1.46 Billion | -7.42 Million |
| Investing Cash Flow | -48.17 Million | -56.95 Million | -53.07 Million | 815.51 Million | 102.45 Million | -142.76 Million |
| Investments in PPE | -33.32 Million | -29.7 Million | -32.24 Million | -28.78 Million | -31.88 Million | -48.86 Million |
| Acquisitions | -6.66 Million | -28.16 Million | -5.2 Million | -1.14 Million | 137.75 Million | -91.72 Million |
| Investment purchases | -31.89 Million | -17.34 Million | -35.05 Million | -61.84 Million | -35.1 Million | -15.88 Million |
| Sales/Maturities of investments | 22.9 Million | 16.88 Million | 16.49 Million | 33.43 Million | 51.1 Million | 13.71 Million |
| Other Investing Activities | 807 Thousand | 1.37 Million | 2.93 Million | 873.85 Million | -19.42 Million | -18.38 Million |
| Financing Cash Flow | -25.71 Million | -487.55 Million | -760.11 Million | -4.15 Million | -393.07 Million | -170.61 Million |
| Debt repayment | -19.11 Million | -1.88 Billion | -762.65 Million | -528.66 Million | -1.98 Billion | -2.09 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -919 Thousand | -88.51 Million | -4.71 Million | -8.49 Million | -145.28 Million | -302.16 Million |
| Common Stock Issuance | 4.91 Million | 5.39 Million | 6.85 Million | 7 Million | 11.25 Million | 16.25 Million |
| Other Financing Activities | -10.59 Million | 1.48 Billion | 407 Thousand | 1.05 Billion | 3.47 Billion | 4.43 Billion |
| Accounts receivables | 26.27 Million | -5.54 Million | -72.73 Million | 37.93 Million | 7.85 Million | -36.59 Million |
| Accounts payables | -11.92 Million | 420 Thousand | 21.32 Million | 47.9 Million | 104.16 Million | 15.39 Million |
| Inventory | - | - | - | -54.88 Million | -34.11 Million | -66.72 Million |
| Other working capital | -37.9 Million | 36.95 Million | 28.04 Million | 21.77 Million | 19.34 Million | -9.17 Million |
| Cash at beginning of period | 9.82 Million | 387.39 Million | 1.12 Billion | 107.87 Million | 56.74 Million | 80.2 Million |
| Cash at end of period | 73.25 Million | 9.82 Million | 387.39 Million | 1.12 Billion | 112.76 Million | 56.74 Million |
| Capital Expenditure | -33.32 Million | -29.7 Million | -32.24 Million | -28.78 Million | -31.88 Million | -48.86 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 63.43 Million | -377.56 Million | -736.45 Million | 1.01 Billion | 56.02 Million | -23.45 Million |
| Free Cash Flow | 103.99 Million | 137.23 Million | 44.48 Million | 175.83 Million | 314.75 Million | 241.05 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 19.44 Million | -153.02 Million | 4.03 Million | -124.28 Million | -60.4 Million | 21.39 Million |
| Depreciation & Amortization | 6.95 Million | 8.79 Million | 10.3 Million | 9.06 Million | 36.17 Million | 9.21 Million |
| Deferred income taxes | 9.14 Million | -25.71 Million | 686 Thousand | -7.35 Million | 3.23 Million | 2.21 Million |
| Stock-based compensation | 4.11 Million | 1.95 Million | 3.06 Million | 3.02 Million | 12.32 Million | 3.16 Million |
| Change in working capital | 55.04 Million | 84.6 Million | -139.65 Million | 25.57 Million | -11.62 Million | 45.56 Million |
| Other non-cash items | 6.01 Million | 142.32 Million | -1.06 Million | 163.22 Million | 157.62 Million | -1.6 Million |
| Investing Cash Flow | -4.33 Million | -12.89 Million | -16.23 Million | -12.42 Million | -48.17 Million | -14 Million |
| Investments in PPE | -6.29 Million | -6.96 Million | -5.33 Million | -9.04 Million | -33.32 Million | -9.15 Million |
| Acquisitions | - | - | -8.16 Million | -5 Million | -6.66 Million | - |
| Investment purchases | -14.48 Million | -23.01 Million | -16.89 Million | -5.41 Million | -31.89 Million | -8.71 Million |
| Sales/Maturities of investments | 14.08 Million | 17.08 Million | 14.15 Million | 6.34 Million | 22.9 Million | 3.75 Million |
| Other Investing Activities | 2.35 Million | -5.93 Million | -2.74 Million | 691 Thousand | 807 Thousand | 116 Thousand |
| Financing Cash Flow | -3.07 Million | -82.65 Million | 76.2 Million | -4.74 Million | -25.71 Million | -50.6 Million |
| Debt repayment | -157.96 Million | -83.82 Million | -76.18 Million | -3.63 Million | -19.11 Million | -44.82 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -162 Thousand | -11 Thousand | -887 Thousand | 919 Thousand | -919 Thousand | -133 Thousand |
| Common Stock Issuance | 897 Thousand | 1.14 Million | 860 Thousand | 1.03 Million | 4.91 Million | 1.18 Million |
| Other Financing Activities | 154.16 Million | 33 Thousand | 46 Thousand | -2.14 Million | -10.59 Million | -6.83 Million |
| Accounts receivables | 1.56 Million | 9 Million | -9.93 Million | 4.18 Million | 26.27 Million | -6.8 Million |
| Accounts payables | 48.76 Million | 58.54 Million | -141.46 Million | 56.11 Million | -11.92 Million | 41.19 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -25.78 Million | 17.05 Million | 8.72 Million | 21.39 Million | -37.9 Million | 11.17 Million |
| Cash at beginning of period | 19.4 Million | 7.99 Million | 73.25 Million | 21.17 Million | 9.82 Million | 5.84 Million |
| Cash at end of period | 103.83 Million | 19.4 Million | 7.99 Million | 73.25 Million | 73.25 Million | 21.17 Million |
| Capital Expenditure | -6.29 Million | -6.96 Million | -5.33 Million | -9.04 Million | -33.32 Million | -9.15 Million |
| Effect of forex changes on cash | - | - | - | -3.1 Million | - | -6.11 Million |
| Net cash flow / Change in cash | 84.42 Million | 11.4 Million | -65.26 Million | 52.07 Million | 63.43 Million | 15.33 Million |
| Free Cash Flow | 94.43 Million | 99.98 Million | -130.55 Million | 60.2 Million | 103.99 Million | 70.78 Million |
CISTRO
PTXKY
688561
603348
688619
3028